Lessons learned from COVID-19 for the post-antibiotic future
| dc.contributor.author | Wilson LA | |
| dc.contributor.author | Rogers Van Katwyk S | |
| dc.contributor.author | Fafard P | |
| dc.contributor.author | Viens AM | |
| dc.contributor.author | Hoffman SJ | |
| dc.date.accessioned | 2021-04-05T15:48:39Z | |
| dc.date.available | 2021-04-05T15:48:39Z | |
| dc.date.issued | 2020-12 | |
| dc.date.updated | 2021-04-05T15:48:36Z | |
| dc.description.abstract | <jats:title>Abstract</jats:title> <jats:sec> <jats:title>Introduction</jats:title> <jats:p>COVID-19 has rapidly and radically changed the face of human health and social interaction. As was the case with COVID-19, the world is similarly unprepared to respond to antimicrobial resistance (AMR) and the challenges it will produce. COVID-19 presents an opportunity to examine how the international community might better respond to the growing AMR threat.</jats:p> </jats:sec> <jats:sec> <jats:title>Main body</jats:title> <jats:p>The impacts of COVID-19 have manifested in health system, economic, social, and global political implications. Increasing AMR will also present challenges in these domains. As seen with COVID-19, increasing healthcare usage and resource scarcity may lead to ethical dilemmas about prioritization of care; unemployment and economic downturn may disproportionately impact people in industries reliant on human interaction (especially women); and international cooperation may be compromised as nations strive to minimize outbreaks within their own borders.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusion</jats:title> <jats:p>AMR represents a slow-moving disaster that offers a unique opportunity to proactively develop interventions to mitigate its impact. The world’s attention is currently rightfully focused on responding to COVID-19, but there is a moral imperative to take stock of lessons learned and opportunities to prepare for the next global health emergency.</jats:p> </jats:sec> | |
| dc.identifier.citation | Wilson, L.A., Rogers Van Katwyk, S., Fafard, P. et al. Lessons learned from COVID-19 for the post-antibiotic future. Global Health 16, 94 (2020). https://doi.org/10.1186/s12992-020-00623-x | en_US |
| dc.identifier.doi | https://doi.org/10.1186/s12992-020-00623-x | |
| dc.identifier.issn | 1744-8603 | |
| dc.identifier.issn | 1744-8603 | |
| dc.identifier.uri | http://hdl.handle.net/11375/26278 | |
| dc.publisher | Springer Science and Business Media LLC | |
| dc.rights.license | Attribution - CC BY | |
| dc.rights.uri | 2 | |
| dc.subject | Antimicrobial resistance | |
| dc.subject | COVID-19 | |
| dc.subject | Emergency preparedness | |
| dc.subject | International cooperation | |
| dc.subject | Anti-Bacterial Agents | |
| dc.subject | COVID-19 | |
| dc.subject | Coronavirus Infections | |
| dc.subject | Disaster Planning | |
| dc.subject | Drug Resistance, Microbial | |
| dc.subject | Forecasting | |
| dc.subject | Global Health | |
| dc.subject | Humans | |
| dc.subject | International Cooperation | |
| dc.subject | Pandemics | |
| dc.subject | Pneumonia, Viral | |
| dc.title | Lessons learned from COVID-19 for the post-antibiotic future | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Lessons learned from COVID-19 for the post-antibiotic future.pdf
- Size:
- 450.99 KB
- Format:
- Adobe Portable Document Format
- Description:
- Published version